Breaking News Instant updates and real-time market news.

TSLA

Tesla

$315.44

2.67 (0.85%)

, GM

General Motors

$39.02

0.39 (1.01%)

10:55
02/12/19
02/12
10:55
02/12/19
10:55

Morgan Stanley autos analysts to hold an analyst/industry conference call

Autos & Shared Mobility Equity Research Analyst Jonas, along with Credit Desk Analysts McAuliffe & Gomolinski-Ekel, discuss the dynamics driving cross capital structure moves for Tesla, General Motors, Ford and Fiat, as well as their outlooks for 2019 on the back of recent earnings, on an Analyst/Industry conference call to be held on February 12 at 11:30 am.

TSLA

Tesla

$315.44

2.67 (0.85%)

GM

General Motors

$39.02

0.39 (1.01%)

F

Ford

$8.41

0.075 (0.90%)

FCAU

Fiat Chrysler

$14.62

0.06 (0.41%)

  • 12

    Feb

  • 20

    Feb

  • 21

    Feb

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

TSLA Tesla
$315.44

2.67 (0.85%)

02/11/19
02/11/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Hold at Canaccord with analyst Jed Dorsheimer saying he thinks electric vehicle, or EV, penetration is underappreciated by Wall Street. 2. Avis Budget (CAR) upgraded to Buy from Sell at Goldman Sachs with analyst David Tamberrino saying trading at 6.2 times estimated 2019 EBITDA versus a historical trough multiple of 5.9 times and long-term average 8.4 times, shares of Avis look attractive for mean reversion. 3. Electronic Arts (EA) upgraded to Buy from Neutral at BofA/Merrill with analyst Justin Post citing the surprise start to Apex Legends' new Battle Royale. 4. Hasbro (HAS) upgraded to Buy from Neutral at Monness Crespi. 5. Lloyds Banking (LYG) upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/11/19
ADAM
02/11/19
UPGRADE
Target $450
ADAM
Buy
Canaccord upgrades Tesla to Buy with Model 3, governance concerns eased
As previously reported, Canaccord upgraded Tesla to Buy from Hold with analyst Jed Dorsheimer stating that he thinks electric vehicle, or EV, penetration is underappreciated by Wall Street. He believes the last two quarters and recent guidance have removed significant concerns for both production capability and profitability of the Model 3. Also, his prior corporate governance concerns were allayed with the addition of Larry Ellison and Ms. Wilson-Thompson as independent directors, Dorsheimer tells investors. Additionally, he sees Tesla as having "an almost insurmountable lead in autonomous driving," the analyst added in his upgrade note. He raised his price target on Tesla shares to $450 from $330.
02/11/19
ADAM
02/11/19
UPGRADE
ADAM
Buy
Tesla upgraded to Buy from Hold at Canaccord
02/05/19
MSCO
02/05/19
NO CHANGE
Target $283
MSCO
Equal Weight
Morgan Stanley says Tesla managing expectations well, but stock fully valued
Morgan Stanley analyst Adam Jonas said Tesla has "very effectively managed expectations for 1Q19 and the full year," but he also believes the stock remains fully valued. Following the company's recent quarterly report, Jonas cut his 2019 unit volume forecast by 8% to 380,000 vehicles, which drove down his 2019 revenue view to $28B from $30B and led him to lower his price target on Tesla shares to $283 from $291. Jonas, who does not believe investors will assume the company is fully self-sufficient from a funding standpoint without a more sustained period of execution despite its recently strong results, keeps an Equal Weight rating on Tesla shares.
GM General Motors
$39.02

0.39 (1.01%)

01/18/19
MSCO
01/18/19
NO CHANGE
Target $44
MSCO
Overweight
Morgan Stanley raises GM estimates, keeps $44 target after investor day
Following General Motors' investor day, Morgan Stanley analyst Adam Jonas raised his 2019 EPS estimate by 30% to $5.75 from $4.43, though he noted that forecast is still 7% below consensus and 15% below the midpoint of GM's 2019 guidance. He also raised his 2020 EPS forecast by 23% to $4.75 from $3.85, citing the company's cost cutting efforts. While many view GM as a "self help story" that can cut costs faster than the pace of industry headwinds, Jonas said he does "not subscribe to this view." He also reduced his estimate of the value of GM Cruise to $9B from $11.5B, which he notes is "far below" the post-money valuations implied by recent strategic capital raises, stating that he is increasingly cautious on the ability to remove the safety-driver from autonomous vehicles. Jonas keeps an Overweight rating and $44 price target on GM shares, but "with somewhat reduced conviction out of respect for factors largely outside of GM's control."
01/28/19
BMOC
01/28/19
NO CHANGE
BMOC
BorgWarner, Gentherm, Visteon, Autolive price targets raised at BMO Capital
BMO Capital analyst Richard Carlso is turning more bullish on the auto and mobility equipment industry, saying the sentiment from the most recent CES, Detroit Auto Show, and GM's (GM) Capital Markets Day events has shifted his outlook from "cautious" to "cautiously optimistic". The analyst attributes the snap-back rally in the sector stocks' prices to increased optimism over the impact of lingering trade issues and outlooks from companies that have so far updated on their Q4 performance, all of which suggested that the 2018-end declines were overextended. Carlson is raising his price target on Autoliv (ALV) to $84 from $79, on Gentex (GNTX) to $27 from $24, on Aptiv (APTV) to $84 from $74, on Veoneer (VNE) to $41 from $36, on BorgWarner (BWA) to $49 from $44, and on Visteon (VC) to $91 from $84.
01/30/19
MSCO
01/30/19
NO CHANGE
Target $57
MSCO
Equal Weight
Morgan Stanley skeptical of CDK reports on Cars.com bid, GM loss
Morgan Stanley analyst Brian Essex says he remains skeptical of reports that CDK Global (CDK) may make a takeover bid for Cars.com (CARS). Several previous reports had CDK involved in a transaction that never materialized, Essex tells investors in an intraday research note. The analyst says that while a deal with Cars.com could make strategic sense, he would need to see compelling valuation, evidence of fundamental improvement, and synergy dynamics "in order for it to make sense." He's also skeptical of news regarding the loss of General Motors (GM), CDK Global's largest customer. CDK has highlighted on its past few earnings calls revenue declines associated with a pullback in advertising spending at GM, "but we understand they remain a substantial customer of CDK," Essex writes. He keeps an Equal Weight rating on CDK Global with a $57 price target. The stock in afternoon trading is down 5%, or $2.78, to $48.46. Cars.com, on the other hand, is up 5%, or $1.22, to $27.24.
02/08/19
SBSH
02/08/19
NO CHANGE
Target $67
SBSH
Buy
General Motors price target raised to $67 from $60 at Citi
Citi analyst Itay Michaeli raised his price target for General Motors to $67 to reflect higher estimates and roll forward to 2019 numbers. The analyst believes GM's "unique fundamental position" and the path to his prior $76-$134 per share long-term upside potential case "have probably never been as visible as they are today." He keeps a Buy rating on the name.
F Ford
$8.41

0.075 (0.90%)

12/18/18
MSCO
12/18/18
NO CHANGE
Target $10
MSCO
Equal Weight
Ford potential dividend cut could be a buy signal, says Morgan Stanley
Morgan Stanley analyst Adam Jonas said he continues to expect Ford to cut its dividend in half during 2019, but such a potential cut of the dividend could be a buy signal in his view. Such a cut would be a sign that Ford is prepared to make a stronger commitment to sustainable technology than he believes has been demonstrated thus far, Jonas explained. The analyst, who thinks Ford's decisions in the next 6 months could set the tone for the stock over the next several years, also forecasts Ford will undertake a "very significant" restructuring over the next 12 to 18 months that could reduce the size of the company's footprint by more than 25% and include as much as 25,000 headcount cuts. Jonas maintains an Equal Weight rating and $10 price target on Ford shares.
01/15/19
MSCO
01/15/19
NO CHANGE
Target $10
MSCO
Equal Weight
Morgan Stanley says 'wouldn't get too excited' about Ford alliance with VW
Morgan Stanley analyst Adam Jonas said he "wouldn't get too excited" about Ford's (F) alliance with Volkswagen (VLKAY) as he believes Ford must tackle its fundamental and business model challenges mainly on its own. "Over 100%" of Ford's equity valuation is driven by the F-Series, which is largely independent from anything VW could offer, said Jonas, who keeps an Equal Weight rating and $10 price target on Ford shares.
01/15/19
GSCO
01/15/19
NO CHANGE
Target $12
GSCO
Buy
Ford, Volkswagen alliance could result in meaningful savings, says Goldman Sachs
Goldman Sachs analyst David Tamberrino notes that Ford (F) and Volkswagen (VLKAY) have announced their intention to make a formal announcement regarding potential joint plans at the Detroit Auto Show. He believes the expectation is for a deep alliance between the two with respect to passenger cars, developing electric vehicles, as well as investing in Autonomous Vehicle development, among other areas requiring stepped up auto investment or a dramatic change. Ultimately, Tamberrino thinks this could be additive to Ford's outlined restructuring plans and generate shared costs across the alliance, potentially improving near-term and longer-term results. Looking at historical automotive alliances and cost savings realized, there is potential for a range of $1.5B-$4.5B of expense savings that could accrue to Ford, he contends. The analyst reiterates a Buy rating and $12 price target on Ford's shares.
01/23/19
MSCO
01/23/19
NO CHANGE
Target $10
MSCO
Equal Weight
Ford EPS to fall to under 60c from 2020-2022, says Morgan Stanley
Morgan Stanley analyst Adam Jonas "tweaked" his 2019 EPS estimate for Ford to 85c from 83c after the Detroit auto show and the company's report of preliminary 2018 results, noting that he forecasts 2019 revenues to be down 2.4%, primarily due to expectations for a loss of global market share and a 4% decline in volume. However, Jonas added that he sees earnings falling further, to under 60c per share, from 2020 through 2022, noting that his EPS estimates are about one-third below consensus. He expects Ford's dividend to be unchanged for the current quarter, but expects a 50% dividend cut from the second quarter of 2019 on, Jonas added. He maintains an Equal Weight rating and $10 price target on Ford shares ahead of the company's report of Q4 results after today's close.
FCAU Fiat Chrysler
$14.62

0.06 (0.41%)

11/05/18
SOCG
11/05/18
UPGRADE
SOCG
Buy
Fiat Chrysler upgraded to Buy from Hold at Societe Generale
02/08/19
LEHM
02/08/19
DOWNGRADE
LEHM
Equal Weight
Fiat Chrysler downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Brian Johnson downgraded Fiat Chrysler to Equal Weight and lowered his price target for the shares to EUR 15 from EUR 18. The analyst is surprised by the "NAFTA earnings plateau" and views the company's 2020 targets as aggressive. Fiat's NAFTA region sales were below estimates in Q4 and also in its outlook, says Johnson.
02/08/19
02/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fiat Chrysler (FCAU) downgraded to Equal Weight from Overweight at Barclays with analyst Brian Johnson saying he is surprised by the "NAFTA earnings plateau" and views the company's 2020 targets as aggressive. 2. Kellogg (K) downgraded to Hold from Buy at Pivotal Research with analyst Timothy Ramey saying the company's adjusted earnings in Q4 disappointed and it "celebrated 0% organic top line growth for the year citing the heavy lift of reversing the negative trajectory." 3. NXP Semiconductors (NXPI) downgraded to Neutral from Buy at Mizuho with analyst Vijay Rakesh saying with the stock up 40% from the December lows, high China auto inventory and Europe's Worldwide Harmonised Light Vehicle Test Procedure "could present challenges and limit upside." 4. Synaptics (SYNA) downgraded to Neutral from Overweight at JPMorgan with analyst Paul Coster saying the company reported "solid" fiscal Q2 results, driven by further improvement in gross margins, but issued "slightly disappointing" Q3 guidance owing to soft demand in the handset market. 5. Knowles (KN) downgraded to Hold from Buy at Lake Street with analyst Jaeson Schmidt saying while the company can be the dominant player in the market and think its share at Apple (AAPL) is set to remain stable in the future, increasing uncertainty on the health of the global smartphone market could create headwinds to the stock's multiple. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/29/18
SPHN
10/29/18
NO CHANGE
SPHN
Equal Weight
Stephens sees positive take-aways from Auto Finance Summit for Ally Financial
After having attended the Auto Finance Summit in Las Vegas last week, Stephens analyst Vincent Caintic said he is a bit more positive in the near-term on Ally Financial (ALLY), citing the combination of their "timely pivot" to used cars combined with strong dealer relationships that he sees helping them take market share. The analyst added that he thinks America's Car-Mart (CRMT) should benefit, like Ally, from the affordability issue facing consumers. He also believes Santander Consumer (SC) should get bought by Fiat Chrysler (FCAU), but Caintic noted that he heard various opinions at the industry event on the merits of Santander versus another subprime lender. Caintic has Equal Weight ratings on Ally, America's Car-Mart and Santander Consumer.

TODAY'S FREE FLY STORIES

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.